Page last updated: 2024-08-16

resveratrol and angiotensin ii

resveratrol has been researched along with angiotensin ii in 38 studies

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	16 (42.11)	29.6817
2010's	18 (47.37)	24.3611
2020's	4 (10.53)	2.80

Authors

Authors	Studies
Dirsch, VM; Griendling, KK; Haider, UG; Sorescu, D; Vollmar, AM	1
Chan, P; Chen, JJ; Chen, YL; Cheng, CF; Cheng, TH; Huang, MT; Lin, H; Liu, JC; Shih, NL	1
Bomser, JA; Meszaros, JG; Naugle, JE; Olson, ER; Zhang, X	1
Hao, DL; Huang, Y; Hui, RT; Li, HL; Liang, CC; Lin, M; Liu, DP; Liu, G; Liu, YQ; Wang, AB; Wei, C; Williams, GM; Zhang, CN	1
Dirsch, VM; Griendling, KK; Haider, UG; Kontaridis, MI; Neel, BG; Roos, TU; Sorescu, D; Vollmar, AM	1
Chao, HH; Cheng, TH; Juan, SH; Liu, JC; Shyu, KG; Yang, E; Yang, HY	1
Russell, ST; Tisdale, MJ; Wyke, SM	1
Cui, W; Han, C; Jia, X; Li, N; Liu, C; Liu, Z; Mao, W; Song, Y; Wang, W; Zhang, W; Zhang, X	1
Liu, ZP; Liu, ZQ; Song, Y; Zhang, XP	1
Chen, J; Fan, F; Han, L; Wang, S; Wang, X; Xie, X; Yan, J; Zhou, X	1
Alvarez, E; Campos-Toimil, M; Elíes, J; Orallo, F; Verde, I	1
Hashimoto, T; Ichiki, T; Imayama, I; Inanaga, K; Miyazaki, R; Sadoshima, J; Sunagawa, K	1
Fan, FH; Wang, SJ; Wang, XX	1
Hashimoto, T; Ichiki, T; Inanaga, K; Matsuura, H; Miyazaki, R; Sunagawa, K; Takeda, K	1
Akar, F; Sepici, A; Soylemez, S	1
Biala, A; Finckenberg, P; Louhelainen, M; Martonen, E; Merasto, S; Mervaala, E; Muller, DN; Shi, J; Siltanen, A; Tauriainen, E	1
Abu-Taha, M; Cerda-Nicolas, JM; Cortijo, J; Estañ, L; Hermenegildo, C; Issekutz, AC; Morcillo, EJ; Orallo, F; Piqueras, L; Rius, C; Sanz, MJ	1
Atanasov, AG; Dirsch, VM; Erker, T; Gesslbauer, J; Heiss, EH; Joa, H; Kumerz, M; Schachner, D; Schreiner, CE	1
Jiao, JJ; Li, WH; Qu, Q; Wang, QQ	1
Hashimoto, T; Ichiki, T; Kamiharaguchi, A; Kitamoto, S; Matsuura, H; Miyazaki, R; Sunagawa, K; Tokunou, T	1
Jha, RK; Liu, C; Luo, X; Ma, Q; Ma, Z; Qingyuan, Z; Sha, H; Wang, Z; Wu, Z	1
Cao, X; Luo, T; Luo, X; Tang, Z	1
Fu, LJ; Huang, Y; Kong, YL; Liu, J; Lu, LM; Ni, J; Shao, DC; Shen, Y; Wang, Z; Xue, H; Yu, C; Zhang, W; Zhou, L	1
Tan, Y; Yao, F; Zhang, N; Zhang, Q	1
Gao, S; Liang, X; Liu, J; Liu, W; Wan, Z; Wu, Y; Yuan, Z; Zhuo, X	1
Beiroa, D; Diaz-Ruiz, C; Labandeira-Garcia, JL; Rodriguez-Pallares, J; Rodriguez-Perez, AI	1
Xiaoyuan, S; Xinzhong, H	1
Dorri Mashhadi, F; Hafizi, Z; Jamhiri, M; Safari, F; Zare Mehrjardi, F; Zavvar Reza, J	1
Anand-Srivastava, MB; Hossain, E	1
Bartolomucci, A; Beker, DL; Dyck, JRB; Grant, MK; Hamza, SM; Matsumura, N; Parajuli, N; Razzoli, M; Robertson, IM; Soltys, CM; Zordoky, BN	1
Huang, LT; Lin, IC; Lin, YJ; Sheen, JM; Tain, YL; Tiao, MM; Tsai, CC; Tsai, WL; Yu, HR	1
Cheng, C; Huang, Q; Lin, X; Liu, B; Liu, S; Luo, C; Mo, P; Ou, W; Zhong, J	1
Ban, TH; Chang, YS; Choi, BS; Jang, IA; Kim, EN; Kim, MY; Lim, JH; Park, CW; Yoon, HE	1
Alp-Yıldırım, Fİ; Bekpinar, S; Cibali, E; Gultepe, S; Karaca, E; Olgac, V; Uydes-Doğan, BS; Uysal, M; Yamakoğlu, S	1
Akhondzadeh, F; Astani, A; Najjari, R; Ranjbar, AM; Rezvani, ME; Safari, F; Samadi, M; Zare, F	1
Chen, GH; Hu, J; Li, JL; Wang, HN; Xu, T; Yao, HQ	1
El-Kadi, AOS; Shoieb, SM	1
Chen, J; Ma, E; Peng, L; Ren, DN; Wo, D; Wu, C; Yan, H; Zhu, W	1

Other Studies

38 other study(ies) available for resveratrol and angiotensin ii

Article	Year
Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Molecular pharmacology, 2002, Volume: 62, Issue:4 Topics: Angiotensin II; Animals; Aorta; Drug Interactions; Enzyme Activation; Hypertrophy; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Ribosomal Protein S6 Kinases; Stilbenes	2002
Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy. Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 369, Issue:2 Topics: Acetylcysteine; Angiotensin II; Animals; Animals, Newborn; Antioxidants; Cells, Cultured; Hypertrophy; Leucine; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Cardiac; Myosin Heavy Chains; Phosphorylation; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes; Transfection; Ventricular Myosins	2004
Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:3 Topics: Angiotensin II; Animals; Antioxidants; Cell Differentiation; Cell Division; Cells, Cultured; Drug Interactions; Epidermal Growth Factor; Fibroblasts; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Vasoconstrictor Agents	2005
Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free radical biology & medicine, 2005, Jan-15, Volume: 38, Issue:2 Topics: Angiotensin II; Animals; Antioxidants; Aorta; Blood Pressure; Blotting, Western; Cardiomegaly; Dose-Response Relationship, Drug; Echocardiography; Enzyme Activation; Free Radicals; Glutathione Peroxidase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Heart Ventricles; Hydrogen Peroxide; L-Lactate Dehydrogenase; Leucine; Lipid Peroxidation; Malondialdehyde; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Chemical; Myocytes, Cardiac; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Superoxide Dismutase; Time Factors; Transcription Factor AP-1	2005
Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2. Molecular pharmacology, 2005, Volume: 68, Issue:1 Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Epidermal Growth Factor; Intracellular Signaling Peptides and Proteins; Male; Mice; Phosphoproteins; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes	2005
Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells. European journal of pharmacology, 2005, May-16, Volume: 515, Issue:1-3 Topics: Angiotensin II; Animals; Aorta; Binding Sites; Blotting, Northern; Blotting, Western; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Hydrogen Peroxide; Luciferases; Male; Muscle, Smooth, Vascular; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Stilbenes; Transcription Factor AP-1; Transfection	2005
Mechanism of induction of muscle protein degradation by angiotensin II. Cellular signalling, 2006, Volume: 18, Issue:7 Topics: Active Transport, Cell Nucleus; Angiotensin I; Angiotensin II; Animals; Blood Proteins; Cell Line; Enzyme Activation; I-kappa B Kinase; Luciferases; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Naphthalenes; NF-kappa B; Proteasome Endopeptidase Complex; Protein Kinase C; Proteoglycans; Resveratrol; Signal Transduction; Stilbenes; Transcriptional Activation	2006
Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:12 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cardiovascular Agents; Endothelin-1; Hypertension, Renal; Male; Myocardium; Nephrectomy; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes	2005
[Preventive effect of trans-resveratrol on hypertension-induced cardiac hypertrophy in partially nephrectomized rats]. Wei sheng yan jiu = Journal of hygiene research, 2005, Volume: 34, Issue:6 Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Endothelin-1; Hypertension; Male; Myocardium; Nephrectomy; Nitric Oxide; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes	2005
Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway. European journal of pharmacology, 2007, Jul-12, Volume: 567, Issue:1-2 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Proliferation; Cell Size; Cells, Cultured; Cyclic GMP; Fibroblasts; Intracellular Space; L-Lactate Dehydrogenase; Male; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes	2007
Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes. European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine Vasopressin; Blood Vessels; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Fluorescent Dyes; Fura-2; Membrane Potentials; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Rats; Resveratrol; Ryanodine; Stereoisomerism; Stilbenes	2007
SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:7 Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Hypertension; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Niacinamide; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Resveratrol; RNA, Messenger; Sirtuin 1; Sirtuins; Sp1 Transcription Factor; Stilbenes; Time Factors; Transcription, Genetic; Transfection	2008
[Inhibitory effect of resveratrol on cardiac fibroblast proliferation induced by angiotensin II]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2008, Volume: 28, Issue:4 Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Cyclic GMP; Fibroblasts; Gene Expression; Heart; Myocardium; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes	2008
Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis. Hypertension research : official journal of the Japanese Society of Hypertension, 2009, Volume: 32, Issue:6 Topics: Angiotensin II; Animals; Antioxidants; Blood Pressure; Blotting, Northern; Blotting, Western; Body Weight; Cells, Cultured; DNA; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Fibrosis; Heart Rate; Interleukin-6; Luciferases; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Promoter Regions, Genetic; Rats; Resveratrol; Stilbenes; Vascular Diseases	2009
Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats. Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:6 Topics: Acetylcholine; Angiotensin II; Animals; Antioxidants; Endothelium, Vascular; Female; Male; NAD; NADP; Nitric Oxide; Phenylephrine; Rats; Resveratrol; Sex Factors; Stilbenes; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Wine	2009
Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes. Blood pressure, 2010, Volume: 19, Issue:3 Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Genes; Heart; Humans; Hypertension; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes	2010
Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation. Journal of immunology (Baltimore, Md. : 1950), 2010, Sep-15, Volume: 185, Issue:6 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Cardiovascular Diseases; Cell Communication; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Female; Humans; Inflammation Mediators; Male; NF-kappa B; Ovariectomy; PPAR gamma; Rats; Rats, Sprague-Dawley; Resveratrol; Stereoisomerism; Stilbenes; Up-Regulation	2010
Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner. Cardiovascular research, 2011, Apr-01, Volume: 90, Issue:1 Topics: Analysis of Variance; Angiotensin II; Animals; Antioxidants; Cell Shape; Cells, Cultured; Enzyme Activation; Epidermal Growth Factor; Hydrogen Peroxide; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 4; NADPH Oxidases; Oxidation-Reduction; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Time Factors; Transfection	2011
[Effects of resveratrol on the proliferation and CaN of vascular smooth muscle cell induced by angiotensin II]. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2009, Volume: 25, Issue:3 Topics: Angiotensin II; Animals; Calcineurin; Calmodulin; Cell Proliferation; Cells, Cultured; Female; Muscle, Smooth, Vascular; Rabbits; Random Allocation; Resveratrol; Stilbenes	2009
Resveratrol attenuates angiotensin II-induced senescence of vascular smooth muscle cells. Regulatory peptides, 2012, Aug-20, Volume: 177, Issue:1-3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; beta-Galactosidase; Blotting, Western; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme Assays; Imidazoles; Losartan; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Resveratrol; Stilbenes; Tumor Suppressor Protein p53	2012
Resveratrol suppresses microcirculatory disturbance in a rat model of severe acute pancreatitis. Cell biochemistry and biophysics, 2013, Volume: 67, Issue:3 Topics: Acute Disease; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Endothelins; Microcirculation; Nitric Oxide; Pancreas; Pancreatitis; Rats; Rats, Sprague-Dawley; Renin; Resveratrol; Stilbenes; Taurocholic Acid	2013
Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice. Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:9 Topics: Adenylate Kinase; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Mice; Muscle Contraction; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Resveratrol; rho-Associated Kinases; rhoA GTP-Binding Protein; Stilbenes	2014
Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney. Acta pharmacologica Sinica, 2014, Volume: 35, Issue:8 Topics: Acetylation; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Line; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Phosphorylation; Rats; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes	2014
Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation. Experimental biology and medicine (Maywood, N.J.), 2015, Volume: 240, Issue:10 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cells, Cultured; Glucosides; Male; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Superoxides; Ventricular Myosins	2015
Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-β1-Smad3 signaling pathway. Chemico-biological interactions, 2015, Feb-05, Volume: 227 Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Collagen; Diabetes Mellitus, Experimental; Fibroblasts; Glucose; Mice; Mice, Inbred C57BL; Myocardium; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Smad3 Protein; Stilbenes; Transforming Growth Factor beta1; Up-Regulation	2015
Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration. Oncotarget, 2015, Sep-29, Volume: 6, Issue:29 Topics: Aging; Angiotensin II; Animals; Brain; Cell Line; Dopaminergic Neurons; Gene Expression Regulation; Homozygote; Humans; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; NADPH Oxidases; Neurodegenerative Diseases; Neuroglia; Neurons; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Resveratrol; Sirtuin 1; Stilbenes; Substantia Nigra	2015
[Effect of resveratrol on aniogtensin II induced cardiomyocytes hypertrophy and FoxO1/MnSOD signaling pathway]. Zhonghua xin xue guan bing za zhi, 2015, Volume: 43, Issue:8 Topics: Angiotensin II; Animals; Animals, Newborn; Forkhead Transcription Factors; Hypertrophy; Myocytes, Cardiac; Nerve Tissue Proteins; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Stilbenes; Superoxide Dismutase	2015
The effect of resveratrol on angiotensin II levels and the rate of transcription of its receptors in the rat cardiac hypertrophy model. The journal of physiological sciences : JPS, 2017, Volume: 67, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Heart; Male; Myocardium; Rats; Rats, Wistar; Resveratrol; RNA, Messenger; Stilbenes; Transcription, Genetic	2017
Resveratrol prevents angiotensin II-induced hypertrophy of vascular smooth muscle cells through the transactivation of growth factor receptors. Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:8 Topics: Angiotensin II; Animals; Antihypertensive Agents; Cell Line; CSK Tyrosine-Protein Kinase; Enzyme Activation; Hypertrophy; Male; Muscle, Smooth, Vascular; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Growth Factor; Resveratrol; Signal Transduction; src-Family Kinases; Stilbenes; Transcriptional Activation	2017
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes. Cardiovascular research, 2018, 08-01, Volume: 114, Issue:10 Topics: Adaptation, Physiological; Angiotensin II; Animals; Blood Pressure; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Enzyme Activation; Heart Diseases; Hypertension; Male; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; Signal Transduction; Time Factors; Ventricular Remodeling	2018
Combined maternal and postnatal high-fat diet leads to metabolic syndrome and is effectively reversed by resveratrol: a multiple-organ study. Scientific reports, 2018, 04-04, Volume: 8, Issue:1 Topics: Adipose Tissue; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Diet, High-Fat; Female; Glucose Tolerance Test; Male; Maternal Nutritional Physiological Phenomena; Metabolic Syndrome; Obesity; Pregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Resveratrol; Sirtuin 1; Triglycerides	2018
Resveratrol inhibits angiotensin II‑induced proliferation of A7r5 cells and decreases neointimal hyperplasia by inhibiting the CaMKII‑HDAC4 signaling pathway. Molecular medicine reports, 2018, Volume: 18, Issue:1 Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Cycle; Cell Line; Histone Deacetylases; Hyperplasia; Male; Neointima; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes	2018
Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney. Nutrients, 2018, Nov-12, Volume: 10, Issue:11 Topics: Albuminuria; Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Collagen Type IV; Fibronectins; Fibrosis; Kidney; Male; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Plant Extracts; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renal Insufficiency, Chronic; Renin-Angiotensin System; Resveratrol; Superoxide Dismutase	2018
Resveratrol ameliorates the cyclosporine-induced vascular and renal impairments: possible impact of the modulation of renin-angiotensin system. Canadian journal of physiology and pharmacology, 2019, Volume: 97, Issue:12 Topics: Angiotensin II; Animals; Aorta; Cyclosporine; Cytoprotection; Dose-Response Relationship, Drug; Gene Expression Regulation; Kidney; Male; NADPH Oxidase 4; Rats; Rats, Wistar; Renin-Angiotensin System; Resveratrol; RNA, Messenger; Vasoconstriction; Vasodilation	2019
Resveratrol suppresses interleukin-6 expression through activation of sirtuin 1 in hypertrophied H9c2 cardiomyoblasts. Journal of cellular physiology, 2020, Volume: 235, Issue:10 Topics: Angiotensin II; Animals; Cardiomegaly; Cell Survival; Cells, Cultured; Gene Expression; Inflammation; Interleukin-6; Myocytes, Cardiac; Rats; Resveratrol; RNA, Messenger; Sirtuin 1; Transcription, Genetic	2020
Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism. Molecular medicine reports, 2020, Volume: 22, Issue:2 Topics: Acyl-CoA Dehydrogenase; Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Autophagy; Beclin-1; Cardiomegaly; Cells, Cultured; Energy Metabolism; Female; Gene Silencing; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pyruvate Kinase; Rats, Sprague-Dawley; Resveratrol; Sirtuins	2020
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites. Molecular and cellular biochemistry, 2020, Volume: 471, Issue:1-2 Topics: Angiotensin II; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Cardiotoxicity; Cell Line; Cytochrome P-450 CYP1B1; Humans; Hydroxyeicosatetraenoic Acids; Myosin Heavy Chains; Protective Agents; Resveratrol; Vasoconstrictor Agents	2020
Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 165 Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure; Mice; Myocytes, Cardiac; NF-kappa B; Rats; Resveratrol; Signal Transduction	2023